Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Aspirin dose in prevention of preeclampsia and maternal fetal complications
IRCT20190826044619N1Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Mar 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of aspirin in preeclampsia (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Incidence of preeclampsia and Maternal and fetal complications. Started Mar 2018; status: completed.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on IRCT20190826044619N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190826044619N1.